Literature DB >> 35221430

COVID-19 infection in a Down syndrome child.

Sunil Malik1, Aarti Kathuria2.   

Abstract

The clinical spectrum of COVID-19 infection varies from asymptomatic to critical illness. In children, it is usually asymptomatic or milder in severity. Younger infants and children with underlying medical illnesses are more prone to develop severe diseases. Fever and cough are common presentations in children. Angiotensin-converting enzyme 2 receptor and transmembrane serine protease 2 are key proteins in the cell entry process of the virus in the gastrointestinal (GI) tract. Children with Down syndrome (DS) have increase mortality rates from COVID-19 compared to the general pediatric population. We are reporting a case of a DS baby with COVID-19 infection who presented with GI manifestations leading to hypernatremic dehydration with multiorgan dysfunction syndrome.
Copyright © Sudanese Association of Pediatricians.

Entities:  

Keywords:  COVID-19; Down syndrome; Infant

Year:  2021        PMID: 35221430      PMCID: PMC8879358          DOI: 10.24911/SJP.106-1615470988

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN: 0256-4408


  9 in total

1.  Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.

Authors:  John Matthai; Naresh Shanmugam; Prasanth Sobhan
Journal:  Indian Pediatr       Date:  2020-06-15       Impact factor: 1.411

Review 2.  Outbreak of COVID-19 infection in children: fear and serenity.

Authors:  P Pavone; M Ceccarelli; R Taibi; G La Rocca; G Nunnari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

3.  Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.

Authors:  Margaret A Turk; Scott D Landes; Margaret K Formica; Katherine D Goss
Journal:  Disabil Health J       Date:  2020-05-24       Impact factor: 2.554

4.  Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis.

Authors:  Jitendra Meena; Jaivinder Yadav; Lokesh Saini; Arushi Yadav; Jogender Kumar
Journal:  Indian Pediatr       Date:  2020-06-24       Impact factor: 1.411

Review 5.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

6.  Down's syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach.

Authors:  Marcos Altable; Juan Moisés de la Serna
Journal:  Neurol Sci       Date:  2020-11-24       Impact factor: 3.307

Review 7.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01

8.  Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.

Authors:  Rita Assaker; Anne-Emmanuelle Colas; Florence Julien-Marsollier; Béatrice Bruneau; Lucile Marsac; Bruno Greff; Nathalie Tri; Charlotte Fait; Christopher Brasher; Souhayl Dahmani
Journal:  Br J Anaesth       Date:  2020-05-31       Impact factor: 9.166

9.  Epidemiological and Clinical Characteristics of COVID-19 in Indian Children in the Initial Phase of the Pandemic.

Authors:  Bhakti Sarangi; Venkat Sandeep Reddy; Jitendra S Oswal; Nandini Malshe; Ajinkya Patil; Manojit Chakraborty; Sanjay Lalwani
Journal:  Indian Pediatr       Date:  2020-07-28       Impact factor: 3.839

  9 in total
  1 in total

1.  Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil.

Authors:  Matheus Negri Boschiero; Camila Vantini Capasso Palamim; Fernando Augusto Lima Marson; Manoela Marques Ortega
Journal:  Hum Genet       Date:  2022-06-28       Impact factor: 5.881

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.